NEW YORK – Based on findings from an integrated genomic, transcriptomic, and epigenomic analysis of acute lymphoblastic leukemia (ALL) cases, a St. Jude Children's Research Hospital-led team has proposed a potential treatment alternative treatment for glucocorticoid steroid-resistant ALL patients.
To read the full story....
...and receive Weekly News bulletins.
Already have a Precision Oncology News or 360Dx or GenomeWeb account?
Login Now.
Don't have a Precision Oncology News or 360Dx or GenomeWeb account?
Register for Free.